- The channel debated why transhumanists often reject performance-enhancing drugs such as anabolic steroids, attributing the stance to “negative publicity via association” rather than technical objections.  
- Participants compared the marginal 15 % strength gain from steroids to the broader goal of absolute human enhancement, questioning whether bodybuilding culture qualifies as transhumanist.  
- Noopept, a Russian-developed nootropic said to be 1 000× more potent than piracetam, was reported to produce subtle improvements in mood and coordination without a dramatic “feel smarter” effect.  
- A proposal emerged for an open, Octopart-like search engine that would combine parametric queries (price per dose, package size, bio-enhanced formulations) with user-shared “regimens” and links to group experiments.  
- The idea of a rigorous “cyborg camp” was floated: volunteers wearing continuous biosensors would run tightly-tracked, single-variable self-experiments, then pool data for Monte-Carlo optimization of personal drug stacks.  
- Concerns were raised about the scientific value of platforms like Genomera, criticized for running “lame experiments” that generate noise rather than actionable answers.  
- Peter Thiel’s new Breakout Labs fund (breakoutlabs.org) was announced as a potential source of early-stage science grants relevant to transhumanist projects.  
- The Royal Society opened its entire journal archive for free permanent access, welcomed as a step toward open scientific knowledge.  
- A Science News article on the BDNF gene’s role in faster skill decay among pilots was shared, linking genetics to individual differences in learning retention.